136 related articles for article (PubMed ID: 6831036)
1. Serum monoclonal immunoglobulin bands in undifferentiated lymphomas of Burkitt and non-Burkitt types.
Magrath I; Benjamin D; Papadopoulos N
Blood; 1983 Apr; 61(4):726-31. PubMed ID: 6831036
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.
Benjamin D; Magrath IT; Maguire R; Janus C; Todd HD; Parsons RG
J Immunol; 1982 Sep; 129(3):1336-42. PubMed ID: 6286763
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy (IgM-kappa) in a patient with Burkitt's lymphoma. Case report and literature review.
Braunstein AH; Keren DF
Arch Pathol Lab Med; 1983 May; 107(5):235-8. PubMed ID: 6404235
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin levels and malaria antibodies in Burkitt's lymphoma.
Nkrumah FK; Sulzer AJ; Maddison SE
Trans R Soc Trop Med Hyg; 1979; 73(1):91-5. PubMed ID: 375487
[TBL] [Abstract][Full Text] [Related]
5. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
Magrath IT; Janus C; Edwards BK; Spiegel R; Jaffe ES; Berard CW; Miliauskas J; Morris K; Barnwell R
Blood; 1984 May; 63(5):1102-11. PubMed ID: 6546890
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of Burkitt's and non-Burkitt's "undifferentiated" malignant lymphoma: immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features.
Grogan TM; Warnke RA; Kaplan HS
Cancer; 1982 May; 49(9):1817-28. PubMed ID: 6804087
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma.
Fialkow PJ; Klein E; Klein G; Clifford P; Singh S
J Exp Med; 1973 Jul; 138(1):89-102. PubMed ID: 4577623
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
9. Immunohistologic detection of immunoglobulins in malignant lymphomas and its value in histopathologic diagnosis.
Radaszkiewicz T; Denk H
Virchows Arch A Pathol Anat Histol; 1979 Feb; 381(2):141-58. PubMed ID: 154762
[No Abstract] [Full Text] [Related]
10. Monoclonal gammopathy (IgM-k) in a patient with Burkitt's type lymphoblastic lymphoma.
Bajetta E; Gasparini G; Facchetti G; Ferrari L; Giardini R; Delia D
Tumori; 1984 Oct; 70(5):403-7. PubMed ID: 6438850
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies.
Katsikis PD; Pavlidis NA; Papadopoulos NM; Bai M; Moutsopoulos HM
Anticancer Res; 1990; 10(6):1719-24. PubMed ID: 2285248
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
[TBL] [Abstract][Full Text] [Related]
13. Excretion of immunoglobulins in Burkitt's lymphoma.
McFarlane H; Barrow RO; Ngu VA; Osunkoya BO
Br J Cancer; 1970 Jun; 24(2):258-9. PubMed ID: 4194925
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
[TBL] [Abstract][Full Text] [Related]
15. Increased natural antibody activity in sera of patients with malignant non-Hodgkin's lymphomas containing paraproteins.
Kourtis AP; Boussiotis VA; Lymberi P; Pangalis GA
Am J Hematol; 1994 Aug; 46(4):283-8. PubMed ID: 8037178
[TBL] [Abstract][Full Text] [Related]
16. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
[TBL] [Abstract][Full Text] [Related]
17. Cell surface and serum monoclonal immunoglobulin in Burkitt's lymphoma.
Williams TL; Weisenburger DD; Gnarra DJ
Arch Pathol Lab Med; 1985 May; 109(5):389. PubMed ID: 3838649
[No Abstract] [Full Text] [Related]
18. Immune marker expression in 53 lymphomas of high-grade malignancy.
Pallesen G; Madsen M; Schifter S
Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
[TBL] [Abstract][Full Text] [Related]
19. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins.
Whicher JT; Wallage M; Fifield R
Clin Chem; 1987 Oct; 33(10):1771-3. PubMed ID: 3117430
[TBL] [Abstract][Full Text] [Related]
20. Small noncleaved follicular center cell (FCC) lymphoma: Burkitt and non-Burkitt variants in the United States. I. Clinical features.
Levine AM; Pavlova Z; Pockros AW; Parker JW; Teitelbaum AH; Paganini-Hill A; Powars DR; Lukes RJ; Feinstein DI
Cancer; 1983 Sep; 52(6):1073-9. PubMed ID: 6349778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
